Argentina Biobanking Market Overview, 2029

Argentina Biobanking Market Overview, 2029

Argentina has been actively promoting the expansion of its biobanking sector to support activities pertaining to genetic medicine and precision healthcare. One of the most well-known projects is PoblAr, which was founded in 2014 with the intention of creating a biobank that is easily available and can be used as a resource for any genomics research involving the Argentine population. By analyzing the most common genomic variants to determine genetic risk factors and create a bridge between the public and private sectors for the development of medications and precision medicine therapies, PoblAr aims to promote genomics in biomedical research and apply precision medicine strategies. In spite of previous obstacles including a lack of funds and political will, government support for financing the execution. Ministerial support has been restored to finance the installation of collecting units at the federal level and secure a physical space for the bio bank, together with skilled people to work with data, despite previous hurdles including lack of financing and political will. the Argentina's dedication to precision medicine research is demonstrated by the creation of a ""state-of-the-art"" cancer-related data and bio bank, demonstrating the country's efforts to advance its biobanking capabilities. Argentina's road map for improved health involves prioritising the establishment of a genomics biobank, encouraging precision medicine at the provincial and national levels, and expanding access to customised care through the use of clinical evidence and registries.Concerns around the usage of genetic data as well as a lack of experience and understanding with data interchange are the goals of these projects.Businesses do this by developing new forms for information. Biobanking sector of Argentina is driven by several key components that support its growth and development. Prominent characteristics of the country that provide an abundance of genetic, environmental, and cultural assets for medical and scientific study are its great diversity and diversified population. Argentina has put in place a number of policies and initiatives aimed at promoting innovation, expanding the study of medicine, and enhancing healthcare provision like Government subsidies and money for infrastructure and medical research are. Another component is the cooperation of research organisations, academic universities, and private partners. The cooperation between research organisations, academic institutions, and commercial partners is an additional element driving the growth of the bio banking industry. These interactions facilitate the exchange of knowledge, skills, and best practices, which accelerates the publication of research findings and treatment development projects. They also foster cooperation and information exchange
.

According to the research report ""Argentina Biobanking Market Overview, 2029,"" published by Bonafide Research, the Argentina Biobanking market is expected to reach a market size of more than USD 590 Million by 2029. The biobanking sector in Argentina includes huge range of products deigned to make it easier to gather, prepare, and store biological specimens for use in clinical and research settings. These product categories include consumables, specialised gear, and laboratory information systems made to specifically address the requirements of the nation's bio banks. Numerous tools and equipment for sample processing, storing, and analysis are employed at biobanking facilities in Argentina. Laboratory centrifuges, automated liquid handling systems, cryogenic storage systems, and ultra-low temperature freezers are a few examples of this equipment. These instruments are necessary to preserve the viability and integrity of biological specimens kept in bio banks, guaranteeing that samples are still appropriate for use in clinical and scientific settings. Another significant product category in the Argentine biobanking industry is consumables, which include a range of items needed for labelling, storing, and gathering samples. Cryovials, storage tubes, cryogenic labels, and preservation solutions are a few examples of these commodities. High-quality consumable sample handling and storage are essential for preserving sample integrity and lowering the possibility of contamination. In the Argentine biobanking industry, laboratory information systems (LIS), which offer software solutions for sample tracking, inventory management, and data documentation, are another essential product category. Biobanks can effectively oversee sample collections, monitor sample utilisation, and keep thorough records of sample information thanks to these tools. LIS systems improve accessibility and security of data, making it easier to comply with regulations and promoting smooth cooperation between institutions and researchers.

In Argentina, clinical diagnosis, medicinal development, and biomedical research are supported by a wide range of services provided by biobanking. The administration of bio banks and repositories, which includes the methodical gathering, processing, and preservation of biological materials including tissues, blood, and DNA, is one essential function. Such repositories offer access to well-characterized samples for a variety of scientific inquiries, making them useful tools for researchers and physicians. In Argentina, the biobanking process depends on validation and qualification services to guarantee the precision, dependability, and traceability of stored specimens and related data. Bio banks follow strict validation procedures to confirm sample integrity, equipment performance, and storage conditions, guaranteeing adherence to industry best practices and legal requirements. Sample preparation, processing, and analysis are among the lab processing services provided by biobanking institutions in Argentina. By providing access to high-quality biological specimens and associated services, bio banks enable researchers and clinicians to advance knowledge, develop new treatments, and improve patient care, ultimately contributing to the advancement of public health and well-being. Maintaining a constant cold temperature is critical for many biospecimens. Cold chain logistics involve the specialized packaging, transportation, and storage of samples at specific temperatures (e.g., ultra-low freezers) to ensure their viability. Consultation on biobanking best practices, ethical considerations, and regulatory compliance is a valuable service offered by bio banks. Biobanking experts provide guidance and support to researchers and institutions on establishing and operating bio banks in accordance with industry standards and legal requirements. Participant recruitment to build bio bank collections is another essential service provided by bio banks. Bio banks actively engage with individuals and communities to recruit participants willing to donate biological samples and share relevant clinical and demographic information. Data analysis services for linked clinical data associated with samples are increasingly offered by bio banks to support translational research and precision medicine efforts.

The biobanking landscape includes a variety of applications and methodologies used in the biobanking process, as well as several types of biobanks, each serving distinct clinical and research goals. Physical biobanks, are biological specimens are kept in controlled environments in physical repositories. These biobanks contains various types of biological samples from patients and research participants, such as tissues, blood, and DNA. By giving researchers and clinicians access to well-characterized samples for a variety of investigations, physical biobanks are essential to advancing biomedical research, clinical diagnostics, and drug development initiatives in Argentina. Virtual biobanks function inside a digital environment, enabling the sharing of biological and clinical data between academics, medical professionals, and organizations. These systems combine and analyses massive datasets, including as genetic data, health records, and research findings, by utilizing informatics technology. In Argentina, virtual biobanks facilitate cooperation and data exchange by giving researchers access to and analysis capabilities for large-scale datasets needed for translational research and precision medicine projects. Usage of this samples are commonly in , drug development, clinical research, personalized medicine, and epidemiological studies are only a few of the many clinical and scientific projects that biobanking in Argentina supports. Biobanks include biological specimens that are essential for researching disease causes, finding biomarkers, and creating new treatments specifically for the Argentine citizen.

Considered in this report
• Historic year: 2018
• Base year: 2023
• Estimated year: 2024
• Forecast year: 2029

Aspects covered in this report
• Biobanking market Outlook with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Equipment
• Consumables
• Laboratory Information Systems

By Service Type
• Biobanking and Repository
• Validation/Qualification
• Lab Processing
• Cold Chain Logistic
• Others

By Biospecimen Type
• Human Tissues
• Stem Cells
• Organs
• Others

By Biobank
• Physical Biobanks
• Virtual Biobanks

By Application
• Drug Discovery and Clinical Research
• Therapeutics
• Clinical Diagnostics
• Others

By Type of Biobank
• Population-based Biobanks
• Disease-oriented Biobanks

By Ownership
• National/regional agency
• Non-Profit Organization
• Universities
• Private Organization

By Storage
• Manual Storage
• Automated Storage

The approach of the report:
This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the Biobanking industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.